Trial intelligence / Profile preview

Ramipril in Early IgA Nephropathy

NCT01225445Phase 3Completed

Sponsor
The Chinese University of Hong Kong
Start
Apr 2002
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ramipril in IgA nephropathy (IgAN), sponsored by The Chinese University of Hong Kong. Started Apr 2002; status: completed.

02

Drugs

ramipril
03

Conditions

IgA nephropathy (IgAN)

Beyond the preview

Go deeper on NCT01225445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01225445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call